{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T19:13:16Z","timestamp":1778699596412,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s10157-021-02020-z","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T18:02:52Z","timestamp":1611770572000},"page":"531-536","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Valganciclovir prophylaxis for cytomegalovirus infection in pediatric kidney transplant recipients: a single-center experience"],"prefix":"10.1007","volume":"25","author":[{"given":"Takaya","family":"Iida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Ban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Ishiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsutoshi","family":"Shiratori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoo","family":"Yabuuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyonobu","family":"Ishizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Takaiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhide","family":"Suyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Hisano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4309-8672","authenticated-orcid":false,"given":"Motoshi","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,27]]},"reference":[{"key":"2020_CR1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/QCO.0b013e328285a358","volume":"20","author":"RH Rubin","year":"2007","unstructured":"Rubin RH. The pathogenesis and clinical management of cytomegalovirus infection in the organ transplant recipient: the end of the \u2018silo hypothesis.\u2019 Curr Opin Infect Dis. 2007;20:399\u2013407.","journal-title":"Curr Opin Infect Dis"},{"key":"2020_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1523-1755.2004.00735.x","volume":"66","author":"S Sagedal","year":"2004","unstructured":"Sagedal S, Hartmann A, Nordal KP, et al. Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. Kidney Int. 2004;66:329\u201337.","journal-title":"Kidney Int"},{"key":"2020_CR3","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1111\/j.1600-6143.2012.04087.x","volume":"12","author":"SF Atabani","year":"2012","unstructured":"Atabani SF, Smith C, Atkinson C, et al. Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy. Am J Transplant. 2012;12:2457\u201364.","journal-title":"Am J Transplant"},{"issue":"Suppl s1","key":"2020_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/ajt.15672","volume":"20","author":"A Hart","year":"2020","unstructured":"Hart A, Smith JM, Skeans MA, et al. OPTN\/SRTR 2018 annual data report: kidney. Am J Transplant. 2020;20(Suppl s1):20\u2013130.","journal-title":"Am J Transplant"},{"key":"2020_CR5","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/TP.0000000000002191","volume":"102","author":"CN Kotton","year":"2018","unstructured":"Kotton CN, Kumar D, Caliendo AM, et al. The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2018;102:900\u201331.","journal-title":"Transplantation"},{"key":"2020_CR6","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/ndt\/gfl151","volume":"21","author":"BH Tan","year":"2006","unstructured":"Tan BH. CMV prophylaxis\u2014to do or not to do, that is the question. Nephrol Dial Transplant. 2006;21:1757\u201361.","journal-title":"Nephrol Dial Transplant"},{"key":"2020_CR7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Mu\u00f1oz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20:629\u201337.","journal-title":"J Am Soc Nephrol"},{"key":"2020_CR8","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s10157-013-0856-y","volume":"18","author":"O Uemura","year":"2014","unstructured":"Uemura O, Nagai T, Ishikura K, et al. Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease. Clin Exp Nephrol. 2014;18:626\u201333.","journal-title":"Clin Exp Nephrol"},{"key":"2020_CR9","first-page":"1098","volume":"317","author":"RD Mosteller","year":"1987","unstructured":"Mosteller RD. Simplified calculation of body-surface area. N Engl J Med. 1987;317:1098.","journal-title":"N Engl J Med"},{"key":"2020_CR10","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1097\/TP.0000000000002259","volume":"102","author":"M Hattori","year":"2018","unstructured":"Hattori M, Mieno M, Shishido S, et al. Outcomes of pediatric ABO-incompatible living kidney transplantations from 2002 to 2015: an analysis of the Japanese kidney transplant registry. Transplantation. 2018;102:1934\u201342.","journal-title":"Transplantation"},{"key":"2020_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/petr.12833","author":"G Varela-Fascinetto","year":"2017","unstructured":"Varela-Fascinetto G, Benchimol C, Reyes-Acevedo R, et al. Tolerability of up to 200 days of prophylaxis with valganciclovir oral solution and\/or film-coated tablets in pediatric kidney transplant recipients at risk of cytomegalovirus disease. Pediatr Transplant. 2017. https:\/\/doi.org\/10.1111\/petr.12833.","journal-title":"Pediatr Transplant"},{"key":"2020_CR12","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1097\/TP.0000000000000888","volume":"100","author":"B H\u00f6cker","year":"2016","unstructured":"H\u00f6cker B, Zencke S, Krupka K, et al. Cytomegalovirus infection in pediatric renal transplantation and the impact of chemoprophylaxis with (Val-)Ganciclovir. Transplantation. 2016;100:862\u201370.","journal-title":"Transplantation"},{"key":"2020_CR13","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1097\/TP.0000000000000570","volume":"99","author":"S Gabardi","year":"2015","unstructured":"Gabardi S, Asipenko N, Fleming J, et al. Evaluation of low- versus high-dose valganciclovir for prevention of cytomegalovirus disease in high-risk renal transplant recipients. Transplantation. 2015;99:1499\u2013505.","journal-title":"Transplantation"},{"key":"2020_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/tid.12349","volume":"17","author":"DR Stevens","year":"2015","unstructured":"Stevens DR, Sawinski D, Blumberg E, Galanakis N, Bloom RD, Trofe-Clark J. Increased risk of breakthrough infection among cytomegalovirus donor-positive\/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis. Transpl Infect Dis. 2015;17:163\u201373.","journal-title":"Transpl Infect Dis"},{"key":"2020_CR15","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/j.1600-6143.2008.02528.x","volume":"9","author":"W Vaudry","year":"2009","unstructured":"Vaudry W, Ettenger R, Jara P, et al. Valganciclovir dosing according to body surface area and renal function in pediatric solid organ transplant recipients. Am J Transplant. 2009;9:636\u201343.","journal-title":"Am J Transplant"},{"key":"2020_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/petr.12179","volume":"18","author":"A \u00c5sberg","year":"2014","unstructured":"\u00c5sberg A, Bjerre A, Neely M. New algorithm for valganciclovir dosing in pediatric solid organ transplant recipients. Pediatr Transplant. 2014;18:103\u201311.","journal-title":"Pediatr Transplant"},{"key":"2020_CR17","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1097\/TP.0000000000002632","volume":"103","author":"A Pappo","year":"2019","unstructured":"Pappo A, Peled O, Berkovitch M, et al. Efficacy and safety of a weight-based dosing regimen of valganciclovir for cytomegalovirus prophylaxis in pediatric solid-organ transplant recipients. Transplantation. 2019;103:1730\u20135.","journal-title":"Transplantation"},{"key":"2020_CR18","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s00431-012-1772-y","volume":"171","author":"O Uemura","year":"2012","unstructured":"Uemura O, Honda M, Matsuyama T, Ishikura K, Hataya H, Nagai T, Ikezumi Y, Fujita N, Ito S, Iijima K, Japanese Society for Pediatric Nephrology, the Committee of Measures for Pediatric CKD. Is the new Schwartz equation derived from serum creatinine and body length suitable for evaluation of renal function in Japanese children? Eur J Pediatr. 2012;171:1401\u20134.","journal-title":"Eur J Pediatr"},{"key":"2020_CR19","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1016\/j.transproceed.2017.10.004","volume":"49","author":"F Halleck","year":"2017","unstructured":"Halleck F, Khadzhynov D, Schrezenmeier E, Lehner L, Budde K, Staeck O. Prolonged low-dose prophylaxis with valganciclovir in cytomegalovirus-negative recipients of kidney transplants from cytomegalovirus-positive donors allows seroconversion and prevents cytomegalovirus disease. Transplant Proc. 2017;49:2280\u20134.","journal-title":"Transplant Proc"},{"key":"2020_CR20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.transproceed.2017.12.025","volume":"50","author":"K Nanmoku","year":"2018","unstructured":"Nanmoku K, Shinzato T, Kubo T, Shimizu T, Kimura T, Yagisawa T. Prevention of late-onset cytomegalovirus infection and disease in donor-positive\/recipient-negative kidney transplant recipients using low-dose valganciclovir. Transplant Proc. 2018;50:124\u20139.","journal-title":"Transplant Proc"},{"key":"2020_CR21","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1111\/j.1600-6143.2005.00797.x","volume":"5","author":"A Humar","year":"2005","unstructured":"Humar A, Mazzulli T, Moussa G, et al. Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+\/R\u2212 transplant recipients. Am J Transplant. 2005;5:1065\u201370.","journal-title":"Am J Transplant"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-021-02020-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-021-02020-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-021-02020-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,11]],"date-time":"2021-04-11T08:12:07Z","timestamp":1618128727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-021-02020-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,27]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["2020"],"URL":"https:\/\/doi.org\/10.1007\/s10157-021-02020-z","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,27]]},"assertion":[{"value":"9 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the ethical principles set out in the Declaration of Helsinki and the ethical guidelines for epidemiological studies issued by the Ministry of Health, Labour and Welfare, Japan. The Ethics Committee of the TWMU approved the study (approval no. 5528).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was waived by giving the patients' parents an opportunity to opt out.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}